Who invested in Shape Therapeutics?
Shape Therapeutics's investors include New Enterprise Associates, Cherubic Ventures, Mission BioCapital and CureDuchenne Ventures.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$260Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
From Shape Therapeutics's own website: 1 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Shape Therapeutics's investors include New Enterprise Associates, Cherubic Ventures, Mission BioCapital and CureDuchenne Ventures.
Shape Therapeutics has raised $260M across 3 rounds since 2019.
Shape Therapeutics's most recent round was a Grant of $112M in Jul 2026.
Its most recent round, $112M in Jul 2026, is also its largest on record.
Shape Therapeutics's first round on record, in Nov 2019, was backed by New Enterprise Associates and CureDuchenne Ventures.
Shape Therapeutics's latest named round is a Grant, in Jul 2026.
Shape Therapeutics is based in the United States.
New Enterprise Associates led the Series A in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.